QuidelOrtho Corporation (QDEL)
NASDAQ: QDEL · Real-Time Price · USD
11.53
+0.29 (2.58%)
Apr 24, 2026, 11:53 AM EDT - Market open
QuidelOrtho Revenue
In the year 2025, QuidelOrtho had annual revenue of $2.73B, down -1.89%. QuidelOrtho had revenue of $723.60M in the quarter ending December 28, 2025, with 2.23% growth.
Revenue (ttm)
$2.73B
Revenue Growth
-1.89%
P/S Ratio
0.29
Revenue / Employee
$420,031
Employees
6,500
Market Cap
784.98M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 28, 2025 | 2.73B | -52.70M | -1.89% |
| Dec 29, 2024 | 2.78B | -214.90M | -7.17% |
| Dec 31, 2023 | 3.00B | -268.20M | -8.21% |
| Jan 1, 2023 | 3.27B | 1.57B | 92.28% |
| Jan 2, 2022 | 1.70B | 36.90M | 2.22% |
| Jan 3, 2021 | 1.66B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Integra LifeSciences Holdings | 1.64B |
| Lumexa Imaging Holdings | 1.02B |
| Avanos Medical | 701.20M |
| Bioventus | 568.09M |
| InMode | 370.50M |
| Cytek Biosciences | 201.49M |
| SI-BONE | 200.93M |
| CeriBell | 89.06M |
QDEL News
- 1 day ago - Understanding and Addressing Syphilis Trends - and What's Being Missed - PRNewsWire
- 4 days ago - TTP Group Announces the Sale of LEX Diagnostics - Business Wire
- 4 days ago - QuidelOrtho Corporation Completes Acquisition of LEX Diagnostics - PRNewsWire
- 7 days ago - QuidelOrtho Stock Sinks To 52-Week Low - Here's Why - Benzinga
- 8 days ago - QuidelOrtho Announces Preliminary Revenue for the First Quarter 2026 and Provides Update on Full-Year 2026 Guidance - PRNewsWire
- 4 weeks ago - Nathaniel Sisitsky Joins QuidelOrtho as Chief Legal Officer - PRNewsWire
- 2 months ago - Faster Cardiac Answers with High‑Sensitivity Troponin - PRNewsWire
- 2 months ago - QuidelOrtho to Present at the 47th Annual Raymond James Institutional Investor Conference - PRNewsWire